A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Colonoscopy

Interventions

DRUG

HSK3486

For induction and maintenance of sedation.

DRUG

Propofol

For induction and maintenance of sedation.

Trial Locations (1)

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors

lead

Sichuan Haisco Pharmaceutical Group Co., Ltd

INDUSTRY

NCT03773042 - A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients | Biotech Hunter | Biotech Hunter